Cetirizine
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Cetirizine | |
|
Articles | |
|---|---|
|
Most recent articles on Cetirizine | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Cetirizine at Clinical Trials.gov Clinical Trials on Cetirizine at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Cetirizine
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Cetirizine Discussion groups on Cetirizine Patient Handouts on Cetirizine Directions to Hospitals Treating Cetirizine Risk calculators and risk factors for Cetirizine
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Cetirizine | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Synonyms / Brand Names:
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753 Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Dosing and Administration
Adults and Children 12 Years of Age and Older: The recommended dose of ZYRTEC-D 12 HOUR™ Extended Release Tablets is one tablet twice daily for adults and children 12 years of age and older.
Dose Adjustment for Renal and Hepatic Impairment: In patients with decreased renal function(creatinine clearance 11-31 mL/min), patients on hemodialysis (creatinine clearance less than 7 mL/min), and in hepatically impaired patients, a dose of one tablet once daily is recommended.
ZYRTEC-D 12 HOUR™ Extended Release Tablets may be given with or without food and should be swallowed whole, avoiding breaking or chewing the tablet.
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
